Sarcoma, Ewing's: Clinical Trials

1 trial for Sarcoma, Ewing's, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Sarcoma, Ewing's: new trials by email Literature Review of Sarcoma, Ewing's trials Research Report on Sarcoma, Ewing's

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)
robatumumab - Osteosarcoma, Sarcoma, Ewing's
Phase 2TerminatedMerck Sharp & Dohme LLC2192008-02-012018-08-23

Narrower conditions

Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Osteosarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Sarcoma (1)

Interventions

robatumumab (1)

Sponsors

Merck Sharp & Dohme LLC (1)

Results publications

PMID 22682017, PMID 27362300